Aberrant cell signaling is also a factor contributing to immunotherapy resistance, such as the PI3K/Akt pathway, Wnt/-linked protein pathway, JAK/STAT/IFN- pathway, and mitogen-activated protein kinase (MAPK) pathway (Munn and Mellor, 2013; Lin and Zhao, 2015)
Aberrant cell signaling is also a factor contributing to immunotherapy resistance, such as the PI3K/Akt pathway, Wnt/-linked protein pathway, JAK/STAT/IFN- pathway, and mitogen-activated protein kinase… Read More »Aberrant cell signaling is also a factor contributing to immunotherapy resistance, such as the PI3K/Akt pathway, Wnt/-linked protein pathway, JAK/STAT/IFN- pathway, and mitogen-activated protein kinase (MAPK) pathway (Munn and Mellor, 2013; Lin and Zhao, 2015)